Spectral dual-layer detector CT-based radiomics-deep learning for predicting pathological aggressiveness of stage I lung adenocarcinoma: discrimination of precursor glandular lesions and invasive adenocarcinomas.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Dual-layer CT spectral features combined with radiomics/deep learning discriminated precursor glandular lesions from invasive stage I lung adenocarcinoma; the pathology-referenced cohort supports a diagnostic imaging result.
Technology: Dual-layer CT spectral features combined with radiomics/deep learning discriminated precursor glandular lesions from invasive stage I lung adenocarcinoma; the pathology-referenced cohort supports a diagnostic imaging result.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Dual-layer CT spectral features combined with radiomics/deep learning discriminated precursor glandular lesions from invasive stage I lung adenocarcinoma; the pathology-referenced cohort supports a diagnostic imaging result.
- Limitation / still unknown
- The reported comparator, reference labels or held-out/external validation was checked; limitations are stated in the case-specific reason.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.21037/tlcr-24-726
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.